Z-138: a new mature B-cell acute lymphoblastic leukemia cell line from a patient with transformed chronic lymphocytic leukemia

被引:32
作者
Estrov, Z
Talpaz, M
Ku, S
Harris, D
Van, Q
Beran, M
Hirsch-Ginsberg, C
Huh, Y
Yee, G
Kurzrock, R
机构
[1] Univ Texas, MD Anderson Cancer Ctr, Dept Bioimmunotherapy, Houston, TX 77030 USA
[2] Univ Texas, MD Anderson Cancer Ctr, Dept Hematol, Houston, TX 77030 USA
[3] Univ Texas, MD Anderson Cancer Ctr, Div Lab Med, Houston, TX 77030 USA
关键词
cell line; chronic lymphocytic leukemia; acute lymphoblastic leukemia;
D O I
10.1016/S0145-2126(97)00191-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We describe a new mature B-cell acute lymphoblastic leukemia (ALL) cell line designated Z-138 that was derived from a patient with chronic lymphocytic leukemia (CLL) whose disease underwent transformation to a rare, aggressive form of mature B-cell ALL. This cell line has an L3 morphology, ultrastructural characteristics of lymphoblasts, B-lineage surface markers and an immunoglobulin heavy-chain gene rearrangement identical to the rearrangement observed in the patient's blasts from whom the cell line was derived. Z-138 cells produce granulocyte-macrophage colony-stimulating factor (GM-CSF) and high levels of granulocyte-CSF (G-CSF), but they do not exhibit a proliferative response to either cytokine. Both the patient's lymphoblasts and Z-138 cells exhibited cytogenetic abnormalities including t(8;14), t(14;18) and a chromosome 11 abnormality similar to the t(11;14) of the parental cells, resulting in marked overexpression of cyclin D1 (BCL-1 (PRAD1)) mRNA in Z-135 cells. Since these karyotypic anomalies have been associated with low grade (t(14;18)), intermediate grade (t(11;14)) and high grade (t(8;14)) lymphomas, their development may be involved in the unusual aggressive transformation of this patient's CLL. (C) 1998 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:341 / 353
页数:13
相关论文
共 66 条
[1]   PROPOSALS FOR CLASSIFICATION OF ACUTE LEUKEMIAS [J].
BENNETT, JM ;
CATOVSKY, D ;
DANIEL, MT ;
FLANDRIN, G ;
GALTON, DAG ;
GRALNICK, HR ;
SULTAN, C .
BRITISH JOURNAL OF HAEMATOLOGY, 1976, 33 (04) :451-&
[2]  
BERGSMA D, 1978, CYTOGENET CELL GENET, V21, P309
[3]  
COHEN A, 1991, BLOOD, V78, P94
[4]   GRANULOCYTE-COLONY-STIMULATING FACTOR, GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR, PIXY-321, STEM-CELL FACTOR, INTERLEUKIN-3, AND INTERLEUKIN-7 - RECEPTOR-BINDING AND EFFECTS ON CLONOGENIC PROLIFERATION IN ACUTE LYMPHOBLASTIC-LEUKEMIA [J].
DRACH, D ;
ESTROV, Z ;
ZHAO, SR ;
DRACH, J ;
CORK, A ;
COLLINS, D ;
KANTARJIAN, H ;
ANDREEFF, M .
LEUKEMIA & LYMPHOMA, 1994, 16 (1-2) :79-88
[5]  
ERIDANI S, 1984, CANCER, V54, P397, DOI 10.1002/1097-0142(19840801)54:3<397::AID-CNCR2820540305>3.0.CO
[6]  
2-P
[7]  
ESTROV Z, 1988, AM J PEDIAT HEMATOL, V10, P288
[8]   INHIBITION OF ACUTE MYELOGENOUS LEUKEMIA BLAST PROLIFERATION BY INTERLEUKIN-1 (IL-1) RECEPTOR ANTAGONIST AND SOLUBLE IL-1 RECEPTORS [J].
ESTROV, Z ;
KURZROCK, R ;
ESTEY, E ;
WETZLER, M ;
FERRAJOLI, A ;
HARRIS, D ;
BLAKE, M ;
GUTTERMAN, JU ;
TALPAZ, M .
BLOOD, 1992, 79 (08) :1938-1945
[9]  
Estrov Z, 1996, J CELL PHYSIOL, V166, P618, DOI 10.1002/(SICI)1097-4652(199603)166:3<618::AID-JCP17>3.0.CO
[10]  
2-2